Harmony Biosciences Holdings (HRMY) — Capital Reinvestment Ratio
Harmony Biosciences Holdings (HRMY) has a Capital Reinvestment Ratio of 0.00x as of September 2025, meaning it reinvests 0% of its operating cash flow ($108.73 Million) in capital expenditures ($71.00K). See HRMY equity financing ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Harmony Biosciences Holdings Capital Reinvestment Ratio (2021–2024)
This chart tracks Harmony Biosciences Holdings's Capital Reinvestment Ratio across 4 annual periods. Check Harmony Biosciences Holdings investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Harmony Biosciences Holdings (2021–2024)
Year-by-year Capital Reinvestment Ratio for Harmony Biosciences Holdings from 2021 to 2024. For live market cap and broader valuation context, see how much is Harmony Biosciences Holdings worth.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.01x | $219.82 Million | $1.15 Million | ▲ +268.8% |
| 2023 | 0.00x | $219.39 Million | $312.00K | ▲ +19.4% |
| 2022 | 0.00x | $144.47 Million | $172.00K | ▼ -60.6% |
| 2021 | 0.00x | $98.56 Million | $298.00K | — |